TX-TL in a tube — S30 lysate and PURE reconstituted systems for rapid genetic circuit prototyping, biosensing, and on-demand biomanufacturing without living cells
Every cell-free protein synthesis (CFPS) reaction begins with a source of translation machinery extracted or reconstituted outside a living cell. Two philosophies dominate the field: crude S30 extract, which harvests the entire ribosome/tRNA/enzyme complement of a lysed E. coli cell in one messy but cheap step, and the PURE system, which rebuilds translation from ~36 individually purified, chromatographically defined components. The choice between them shapes cost, yield, background activity, and how freely the reaction can be re-engineered.
The S30 extract protocol, largely unchanged in principle since the 1960s but heavily optimized by the Swartz lab and successors, converts a flask of growing E. coli into a stable, freezable translation reagent:
Strain and growth: • BL21 or BL21-derived strains (BL21 Star, A19, Rosetta2) grown in rich medium (2×YT or Terrific Broth) to mid-log phase (OD600 ≈ 0.6–3.0 depending on protocol) • High-density fermentation (OD600 up to 10–20) increases extract yield per liter of culture • Cells harvested by centrifugation, washed in S30 buffer (Tris-acetate, Mg-acetate, K-acetate, DTT) to remove residual medium
Lysis: • Sonication: repeated short pulses on ice — simple, scalable to small batches, but heat and shear can damage ribosomes if overdone • French press: single high-pressure pass (~10,000–20,000 psi) through a narrow orifice — more reproducible at larger scale, standard in the Swartz/Jewett lineage of protocols • Bead milling and homogenizers (e.g., microfluidizers) used in industrial-scale extract production • Lysate cleared by low-speed spin (~30,000×g) to remove cell debris, unbroken cells, and membrane fragments — the resulting supernatant is the "S30" fraction (named for the centrifugal force used)
Run-off reaction: • Crude S30 extract still contains active ribosomes stalled mid-translation on endogenous E. coli mRNAs • Incubating the extract at 37°C for 30–80 minutes with Mg2+ and amino acids lets ribosomes "run off" the ends of these transcripts, releasing them • Endogenous mRNA is then degraded by residual nucleases, clearing the ribosome pool for use on the added template — critical for a clean signal and low background translation
Dialysis and flash-freezing: • Extract dialyzed against S30 buffer to remove small metabolites and adjust ionic strength • Aliquoted and flash-frozen in liquid nitrogen; stored at −80°C, stable for months to years • Batch-to-batch variability remains a persistent practical headache — many labs benchmark each new lysate batch against a reference sfGFP reaction before use
Genomically recoded and engineered strains: • Extracts from strains with genomic deletions (e.g., ΔrecA, ΔendA to reduce nuclease activity; release factor 1 knockouts to enable non-standard amino acid incorporation) tailor the extract to particular applications • Cell-free systems built from genomically recoded organisms allow amber codon reassignment for site-specific incorporation of non-canonical amino acids directly in the lysate
Shimizu, Ueda and colleagues (2001, Nature Biotechnology) asked a different question: rather than lyse a cell and use everything in it, what is the minimal defined set of components sufficient to translate mRNA into protein? The answer became the PURE (Protein synthesis Using Recombinant Elements) system:
Components (all individually purified, mostly His-tagged and Ni-affinity purified from E. coli overexpression strains): • Ribosomes: purified 70S E. coli ribosomes • Aminoacyl-tRNA synthetases: all 20, one per amino acid, charging cognate tRNAs • Translation factors: initiation factors IF1/IF2/IF3, elongation factors EF-Tu/EF-G/EF-Ts, release factors RF1/RF2/RF3, ribosome recycling factor RRF • T7 RNA polymerase: for coupled transcription from a DNA template • Energy regeneration enzyme: creatine kinase (with creatine phosphate as substrate) • Total: approximately 36 purified proteins plus tRNAs, [], NTPs, amino acids, and folate cofactors
Why rebuild from scratch: • Zero background: no genomic DNA, no native mRNA, no proteases or nucleases beyond what is deliberately included — every peptide bond formed comes from the template you added • Full compositional control: swap out any single factor (e.g., an orthogonal ribosome, an engineered aminoacyl-tRNA synthetase for a non-canonical amino acid) without perturbing anything else • Reproducibility: purified components have defined concentrations, in contrast to lysate batches that vary lot to lot • Commercial availability: PURExpress (New England Biolabs) and PUREfrex (GeneFrontier) packaged the system for routine lab use
Trade-offs versus S30 lysate: • Cost: PURE is 10–100× more expensive per reaction than lysate-based systems, since every component requires separate recombinant expression and purification • Yield: PURE typically produces 0.1–0.4 mg/mL protein versus 1–4 mg/mL from optimized S30 extract, because the lysate retains hundreds of endogenous metabolic enzymes (glycolysis, nucleotide salvage) that regenerate energy and cofactors far more efficiently than the minimal PURE enzyme set • Background activity: S30 lysate carries proteases, nucleases, and uncharacterized side reactions that can degrade template or product; PURE's defined composition eliminates this at the cost of yield • Customizability: PURE wins decisively when swapping in engineered translation factors or building fully orthogonal genetic codes; S30 wins when raw protein yield and low cost matter most
A rule of thumb used across the field: reach for S30 lysate when you need cheap, high-yield production for prototyping circuits or making milligrams of protein; reach for PURE when you need a clean, fully definable background for biophysical studies, orthogonal translation engineering, or minimal-system origin-of-life research.
A cell-free reaction is only as good as its energy economy. Translation is enormously ATP- and GTP-hungry — four high-energy phosphate bonds are consumed per peptide bond formed — and a batch reaction has no metabolism to replenish them on the fly. The energy regeneration system, together with a balanced amino acid pool, tuned divalent cation concentration, and the DNA or mRNA template itself, determines how long and how productively the reaction runs before it stalls.
Because CFPS reactions run in a closed tube with no cellular respiration, ATP and GTP must be continuously regenerated from the ADP/GDP produced by translation, transcription, and aminoacylation. Several regeneration chemistries dominate the field, each with different cost, longevity, and byproduct profiles:
Phosphoenolpyruvate (PEP) / pyruvate kinase: • Pyruvate kinase transfers a phosphate from PEP to ADP, regenerating ATP; PEP is a relatively expensive substrate but delivers a very high-energy phosphate bond • Historically the workhorse system for early high-yield CFPS reactions (Kim & Swartz, 1999–2001) • Downside: PEP is metabolized quickly and is one of the costliest reagents in the mix at scale, and inorganic phosphate byproduct accumulation can inhibit the reaction over long incubations
Creatine phosphate / creatine kinase: • Creatine kinase transfers phosphate from creatine phosphate to ADP • Cheaper substrate than PEP, widely used in PURE system formulations and many academic S30 protocols • Provides a more modest but longer-lasting energy supply than PEP-based systems
PANOx-SP system (Swartz lab, Stanford): • "PEP-based, ANti-Oxidant, Substrate Phosphorylation" — combines PEP-driven regeneration with oxalic acid and other components to suppress phosphatase side-reactions that waste high-energy phosphate • Also incorporates nicotinamide adenine dinucleotide (NAD) and coenzyme A to support secondary metabolism (limited central carbon flux) that further extends ATP supply • Achieved landmark yields of >1 g/L (1 mg/mL and up) for the first time in an E. coli extract system, establishing that CFPS could reach industrially relevant titers
Cytomim system: • Retains the E. coli cell membrane fraction (rather than removing it during extract clarification), preserving oxidative phosphorylation activity • Substitutes glutamate and other cytoplasm-mimicking ionic conditions for the standard acetate-based buffer, hence "Cytomim" (cytoplasm-mimicking) • Uses endogenous respiratory chain components to regenerate ATP from a simple energy substrate, cutting the need for expensive PEP • Particularly effective for reactions requiring extended run times or disulfide-bonded/membrane protein synthesis where oxidizing conditions matter
Glucose/glycolytic regeneration: • Cheapest substrate option — relies on residual glycolytic enzymes in the crude lysate to convert glucose (or maltodextrin, maltose) into ATP via a truncated glycolysis pathway • Lower peak yield than PANOx-SP but dramatically cheaper per reaction, favored for cost-sensitive applications like paper-based diagnostics and field-deployable biosensors
Beyond the energy system, several additional master-mix components must be balanced for a productive reaction:
Amino acid mix: • All 20 standard amino acids included, typically at 1–2 mM each; several (Cys, Trp, Tyr) are prone to oxidation or poor solubility and are often supplemented at higher relative concentration or added fresh • Amino acid depletion is a major cause of reaction stalling in long-running batch reactions — continuous-exchange cell-free (CECF) systems address this by dialyzing fresh amino acids and energy substrate in while removing byproducts, extending reactions from hours to days
Mg2+ and K+ optimization: • Mg2+ concentration critically affects ribosome fidelity and processivity; too little destabilizes the ribosome-mRNA complex, too much causes non-specific aggregation and misreading • Every new lysate batch or DNA template typically requires a small Mg2+/K+ titration matrix (commonly tested across a 2D grid in a 96-well plate) to find the reaction-specific optimum, usually in the 8–16 mM Mg2+ and 40–150 mM K+ range
PEG crowding agent: • Polyethylene glycol (PEG-8000, typically 2–4% w/v) mimics the macromolecular crowding of the cytoplasm, which in vivo can occupy 20–30% of cell volume with proteins and RNA • Crowding increases effective reactant concentrations and improves both transcription and translation yield, and can improve folding of aggregation-prone products
NTP mix: • ATP, GTP, CTP, UTP supplied for transcription (T7 RNA polymerase is a voracious NTP consumer) in addition to the ATP/GTP consumed directly by translation • NTPs are often the first substrate depleted in short (<2 hour) unoptimized reactions
Template choice — linear PCR product vs. plasmid: • Linear PCR product: fastest to generate (a single PCR reaction, no cloning, no transformation), ideal for testing many genetic designs in parallel, but degraded over time by residual exonucleases in crude S30 lysate unless protected (e.g., GamS protein from bacteriophage λ inhibits RecBCD exonuclease and stabilizes linear DNA) • Circular plasmid: intrinsically nuclease-resistant, generally supports longer and higher-yield reactions, but requires standard cloning and transformation before use — reintroducing exactly the multi-day cycle cell-free prototyping aims to avoid • mRNA template: bypasses transcription entirely, giving the fastest possible protein output and decoupling translation kinetics from transcriptional variability, at the cost of in vitro transcribing and purifying stable mRNA beforehand
The defining feature of cell-free protein synthesis is coupling: T7 RNA polymerase transcribes mRNA from the DNA template while ribosomes simultaneously load onto that nascent transcript and translate it, all in the same well, at the same time — an arrangement that mirrors bacterial (but not eukaryotic) biology and has no equivalent in a living, compartmentalized cell where transcription and translation occur under separate regulatory and spatial control. Reporter fluorescence, tracked continuously on a plate reader, turns this molecular process into a real-time growth curve.
In an intact, growing E. coli cell, ribosomes elongate polypeptides at roughly 15–20 amino acids per second, tightly coordinated with abundant charged tRNA pools, active proofreading, and a cytoplasm evolved specifically to support this throughput. In a cell-free reaction, elongation rates typically drop to 2–5 amino acids per second — a five- to tenfold slowdown with several compounding causes:
Diluted and imbalanced tRNA pools: • Lysate dilution during extract preparation reduces total tRNA and synthetase concentration relative to the packed cytoplasm of a living cell • Some aminoacyl-tRNA synthetases are more abundant than others in the extract, creating codon-specific bottlenecks — rare-codon-rich sequences translate especially slowly
Loss of cellular organization: • In vivo, transcription and translation are physically coupled at the nucleoid, and ribosomes queue efficiently behind RNA polymerase • In a cell-free tube, this spatial coupling is replaced by simple diffusion-limited proximity — still functional, but less kinetically optimized
Energy and cofactor limitations: • As NTP and amino acid pools deplete over the course of the reaction (see Stage 2), elongation rate itself slows even before complete stalling • GTP availability for EF-Tu– and EF-G–mediated elongation steps is a frequent rate-limiting factor in extended reactions
Temperature: • Reactions are commonly run at 29–30°C rather than the 37°C physiological optimum, because lower temperature improves folding yield of complex or aggregation-prone reporter proteins and slightly extends lysate stability, at the direct cost of ribosome speed — a deliberate speed/yield trade-off tunable in real time by adjusting incubation temperature
Despite slower per-ribosome kinetics, aggregate protein output remains high because many ribosomes each load onto and translate the many mRNA copies transcribed continuously by T7 RNA polymerase throughout the reaction — total yield is a product of per-ribosome rate, ribosome loading density, and transcript half-life, not elongation speed alone.
The Noireaux laboratory (University of Minnesota) established TX-TL (transcription-translation) cell-free systems as a quantitative, real-time platform for studying and prototyping genetic circuits, popularizing plate-reader fluorescence kinetics as the standard readout:
Fluorescent reporters: • deGFP: a truncated, cell-free-optimized GFP variant engineered by the Noireaux lab specifically for fast maturation and robust folding in the reducing, non-chaperone-rich environment of a cell-free reaction • sfGFP (superfolder GFP): matures rapidly (tens of minutes) and folds robustly even when fused to poorly-behaved partner proteins, making it a reliable circuit-output reporter • Both report translation output continuously and non-destructively — a single well can be read every 1–5 minutes for the full duration of the reaction without opening the plate
Typical kinetic profile: • Lag phase (0–30 min): T7 RNA polymerase accumulates transcript, chromophore has not yet matured • Exponential rise phase (30 min–3 h): fluorescence climbs steeply as translation output and chromophore maturation both ramp up • Plateau (4–16 h): resource depletion (NTPs, amino acids, energy substrate) slows and eventually halts further protein accumulation; final yield in a standard batch reaction is commonly 0.5–2.5 mg/mL of reporter protein, read out directly against a purified GFP fluorescence standard curve
Resource competition and circuit loading: • Because RNA polymerase, [], NTPs, and amino acids are finite, shared resources drawn from a single common pool, multiple genetic elements expressed simultaneously in the same tube compete for translational and transcriptional capacity — a phenomenon the synthetic biology field calls "loading" or "resource competition" • A strong constitutive reporter can visibly suppress the expression of a second, co-expressed gene simply by monopolizing ribosomes and RNA polymerase — an effect directly measurable by running competing constructs together and comparing fluorescence trajectories to single-construct controls • This makes TX-TL reactions not just a protein factory but a quantitative testbed for resource-aware circuit design: researchers can measure how a toggle switch, oscillator, or logic gate's performance degrades under competing transcriptional/translational load before ever testing the circuit in living cells • The Noireaux lab TX-TL toolbox (open-source protocols, plasmid libraries, and characterized part sets) has become a standard reference platform cited across hundreds of synthetic biology publications for exactly this kind of quantitative, resource-aware circuit characterization
Because transcription and translation run in the same well with no cell wall, no genome replication, and no growth to worry about, an entire fluorescence kinetic trace — lag, rise, and plateau — can be collected from a single 5-microliter reaction in under a day, turning what would be a multi-day cloning-transformation-culturing cycle into a same-afternoon measurement.
Traditional synthetic biology circuit testing requires cloning a construct, transforming it into a living host, growing an overnight culture, and only then measuring performance — a cycle that consumes one to two weeks per design iteration. Cell-free reactions collapse this cycle to hours by testing linear PCR products or plasmids directly in a tube, with no transformation, no culturing, and no possibility of the host cell's own regulatory machinery confounding the measurement.
The single biggest time cost in conventional strain engineering is not designing a genetic circuit but validating it: ligating or Gibson-assembling a construct, transforming competent cells, picking colonies, growing overnight cultures, inducing expression, and finally measuring output — typically a full week or more per design-test cycle, and considerably longer if the first design does not work and must be redesigned.
Cell-free prototyping removes nearly the entire pipeline after DNA assembly:
1. Linear DNA generation: a PCR reaction amplifies the construct of interest directly from a plasmid template or assembles it from synthesized fragments — no cloning into a vector, no transformation, no selection plate, no colony picking 2. Direct addition to TX-TL master mix: the PCR product (protected from exonuclease degradation by GamS protein or chi-site removal) is pipetted straight into a cell-free reaction well 3. Same-day kinetic readout: fluorescence or other reporter signal collected on a plate reader within hours
This workflow is used to screen: • Promoter libraries: dozens to hundreds of promoter variants (varying −35/−10 spacing, UP elements, transcription factor binding sites) tested in parallel wells to rank strength and dynamic range before committing any of them to a genomic integration or plasmid construct • RBS (ribosome binding site) libraries: translation initiation strength titrated across a large combinatorial sequence space, since RBS calculators (e.g., Salis lab RBS Calculator) predictions still benefit from direct experimental confirmation • Toggle switches and bistable circuits: two mutually repressing promoter-repressor pairs tested for switching threshold and hysteresis without needing to maintain a living bistable population, which is prone to noise-driven state-switching during culturing • Riboswitches: ligand-responsive RNA elements tested by simply adding the candidate ligand directly to the cell-free reaction and reading the resulting change in reporter output — a dose-response curve obtainable in a single afternoon • CRISPR-based circuits: dCas9-based repression/activation circuits, guide RNA libraries, and CRISPR logic gates tested directly, since the cell-free reaction can supply Cas protein and guide RNA either from co-expressed templates or as purified reagents added directly to the mix
The practical maturation of cell-free prototyping has produced commercially available, field-ready kits that package a validated TX-TL master mix as a stable, ready-to-use reagent:
myTXTL (Arbor Biosciences): • A commercially available, all-in-one E. coli-based TX-TL master mix sold in single-use aliquots • "Just add DNA" workflow: researchers add only their linear or plasmid DNA template to a pre-formulated tube and incubate — no in-house lysate preparation, extract quality control, or energy-mix optimization required • Widely adopted in both academic synthetic biology courses (enabling hands-on circuit prototyping without a wet lab capable of lysate preparation) and industrial R&D screening pipelines
Sutro Biopharma: • An industrial cell-free platform (built on an E. coli extract system) scaled for pharmaceutical protein production and high-throughput protein engineering campaigns • Uses cell-free synthesis to rapidly screen thousands of protein variants (e.g., antibody fragments, enzyme mutants) for expression and activity in a fraction of the time required by cell-based expression screening, since no transformation or colony-level clonal variability needs to be controlled for
Design-Build-Test-Learn (DBTL) cycle acceleration: • The DBTL framework central to modern synthetic biology explicitly separates "build" (physically constructing a genetic design) from "test" (measuring its performance) — cell-free systems specifically compress the test phase • Because dozens to hundreds of designs can be tested in parallel 96- or 384-well plate format within a single day, the effective iteration rate of the entire DBTL loop increases by roughly an order of magnitude compared to strain-based testing • Design variants that fail cell-free testing (weak expression, toxic intermediate accumulation, poor folding) are discarded before ever consuming the time and reagent cost of strain construction, focusing downstream in vivo validation effort on only the most promising candidates • This same-day iteration speed is particularly valuable early in a project when the design space is large and most variants are expected to fail — cell-free screening lets that failure happen cheaply and quickly rather than after a week of strain-building effort
Once a cell-free reaction can be freeze-dried, embedded in paper, and rehydrated on demand, it stops being merely a benchtop prototyping tool and becomes a deployable technology: room-temperature-stable diagnostics that need no cold chain, portable biomanufacturing units that produce protein wherever they are needed, and rapid-response platforms capable of producing vaccine antigens on a timescale of days rather than the months required by conventional cell-culture-based manufacturing.
Keith Pardee, James Collins, and colleagues demonstrated in a pair of landmark Cell papers (2014, 2016) that cell-free transcription-translation reactions could be freeze-dried directly onto ordinary paper disks, rehydrated with a test sample, and produce a visible colorimetric or fluorescent readout within hours — without refrigeration, without a laboratory, and without any living organism ever leaving containment.
Toehold switch sensors: • A toehold switch is a synthetic riboswitch engineered so that its ribosome binding site and start codon are sequestered in an RNA hairpin, blocking translation by default • A trigger RNA — complementary to a single-stranded "toehold" region — binds and unwinds the hairpin through strand displacement, exposing the RBS and permitting translation of a downstream reporter (commonly LacZ, generating a visible color change, or GFP) • Toehold switches are computationally designed (using nucleic acid folding software to predict and optimize hairpin stability and trigger specificity) and can in principle be designed against nearly any RNA sequence of interest, giving the platform extremely broad target flexibility
Water contamination sensors: • Pardee et al. demonstrated toehold-switch sensors for water contaminants, sensing target nucleic acid or small-molecule-responsive signals and reporting via a visible colorimetric change on the paper disk itself, read out by eye or with a simple smartphone camera
Zika virus diagnostics (2016): • A follow-up paper extended the paper-based platform to Zika virus RNA detection, combining isothermal RNA amplification (NASBA) with toehold-switch sensors printed on paper • The complete diagnostic — freeze-dried reagents, paper substrate, toehold sensor — produced a visible color change in a matter of hours from a clinical-relevant sample, at a materials cost of a few cents per test, without requiring a thermocycler, cold chain, or trained laboratory personnel • This work established a template widely cited as a model for rapid, low-cost, field-deployable nucleic acid diagnostics using cell-free biology rather than PCR-based molecular diagnostics
Room-temperature stability: • Freeze-drying (lyophilization) the cell-free reaction with the paper substrate produces a shelf-stable reagent reported stable for up to approximately one year at room temperature — eliminating the cold-chain requirement that constrains most molecular diagnostics in resource-limited settings
Beyond diagnostics, freeze-dried and portable cell-free reactions are being developed as distributed manufacturing platforms — producing therapeutic or industrially useful proteins on demand, at the point of need, without the fixed infrastructure of a conventional bioreactor facility.
Portable and on-demand biomanufacturing: • DARPA and related defense research funding has specifically supported development of portable cell-free manufacturing units intended to produce protein therapeutics, vaccines, or other biologics in field or austere settings without access to a conventional cell-culture facility • The appeal of cell-free manufacturing for portability is direct: no living cells to keep alive, no risk of genetically modified organism release, no need for sterile fermentation infrastructure — only a stable reagent mix and a DNA template that can be swapped to redirect production to a different target protein in hours rather than the weeks required to re-engineer and re-validate a production cell line • Metabolic engineering principles pioneered in living-cell systems (exemplified by work from the Keasling laboratory on engineered biosynthetic pathways) are increasingly translated into cell-free formats, reconstructing multi-enzyme pathways in a single tube to produce small-molecule products alongside protein products
Rapid vaccine antigen production: • The Jewett laboratory (Northwestern University) has demonstrated cell-free synthesis of glycosylated proteins and conjugate vaccine antigens, incorporating the enzymatic machinery needed for protein glycosylation directly into engineered cell-free extracts — a capability not present in standard E. coli-based CFPS, since E. coli does not natively glycosylate proteins • Cell-free conjugate vaccine production has been explored specifically for its speed advantage: because there is no need to grow, adapt, and validate a production cell line for each new antigen, cell-free platforms can in principle move from a genetic sequence to a candidate antigen preparation in days • This speed advantage has drawn direct interest from DARPA and BARDA (Biomedical Advanced Research and Development Authority) as part of pandemic-preparedness research, on the premise that a portable, cell-free antigen production platform could substantially compress the time between identifying a novel pathogen and producing candidate vaccine material for early-stage testing
Freeze-dried reaction stability enabling deployment: • The same lyophilization technology that stabilizes paper diagnostics for a year at room temperature applies equally to production-scale cell-free reactions, meaning a single stable, pre-formulated reagent batch can be shipped anywhere and activated on demand simply by rehydrating with water and the desired DNA template — collapsing both the cold-chain and the manufacturing-infrastructure requirements that constrain conventional biologics production
The throughline across every scale-up application — paper diagnostics, portable manufacturing, rapid vaccine antigens — is the same property established back in Stage 1's lysate preparation: a cell-free reaction is a stable, storable, decoupled reagent. Once translation machinery is extracted from a living cell and freeze-dried, it can be shipped, stored for a year, and activated anywhere on earth simply by adding water and DNA.